These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 22323550

  • 1. Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
    Aizman E, Mor A, Levy A, George J, Kloog Y.
    Oncotarget; 2012 Feb; 3(2):144-57. PubMed ID: 22323550
    [Abstract] [Full Text] [Related]

  • 2. The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
    Gana-Weisz M, Halaschek-Wiener J, Jansen B, Elad G, Haklai R, Kloog Y.
    Clin Cancer Res; 2002 Feb; 8(2):555-65. PubMed ID: 11839677
    [Abstract] [Full Text] [Related]

  • 3. Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling.
    Barkan B, Kloog Y, Ehrlich M.
    Mol Cancer Ther; 2011 Aug; 10(8):1317-26. PubMed ID: 21632464
    [Abstract] [Full Text] [Related]

  • 4. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
    Charette N, De Saeger C, Lannoy V, Horsmans Y, Leclercq I, Stärkel P.
    Mol Cancer; 2010 Sep 22; 9():256. PubMed ID: 20860815
    [Abstract] [Full Text] [Related]

  • 5. RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma.
    Jiang C, Song T, Li J, Ao F, Gong X, Lu Y, Zhang C, Chen L, Liu Y, He H, Huang O.
    Mol Neurobiol; 2017 Jan 22; 54(1):779-787. PubMed ID: 27021020
    [Abstract] [Full Text] [Related]

  • 6. Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice.
    Haklai R, Elad-Sfadia G, Egozi Y, Kloog Y.
    Cancer Chemother Pharmacol; 2008 Jan 22; 61(1):89-96. PubMed ID: 17909812
    [Abstract] [Full Text] [Related]

  • 7. Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells.
    Erlich S, Tal-Or P, Liebling R, Blum R, Karunagaran D, Kloog Y, Pinkas-Kramarski R.
    Biochem Pharmacol; 2006 Aug 14; 72(4):427-36. PubMed ID: 16780807
    [Abstract] [Full Text] [Related]

  • 8. Ras inhibits endoplasmic reticulum stress in human cancer cells with amplified Myc.
    Yaari-Stark S, Shaked M, Nevo-Caspi Y, Jacob-Hircsh J, Shamir R, Rechavi G, Kloog Y.
    Int J Cancer; 2010 May 15; 126(10):2268-81. PubMed ID: 19998334
    [Abstract] [Full Text] [Related]

  • 9. Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist.
    Egozi Y, Weisz B, Gana-Weisz M, Ben-Baruch G, Kloog Y.
    Int J Cancer; 1999 Mar 15; 80(6):911-8. PubMed ID: 10074926
    [Abstract] [Full Text] [Related]

  • 10. Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
    Levy R, Grafi-Cohen M, Kraiem Z, Kloog Y.
    Mol Cancer Ther; 2010 Aug 15; 9(8):2208-19. PubMed ID: 20682656
    [Abstract] [Full Text] [Related]

  • 11. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Goldberg L, Haklai R, Bauer V, Heiss A, Kloog Y.
    J Med Chem; 2009 Jan 08; 52(1):197-205. PubMed ID: 19072665
    [Abstract] [Full Text] [Related]

  • 12. Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice.
    George J, Afek A, Keren P, Herz I, Goldberg I, Haklai R, Kloog Y, Keren G.
    Circulation; 2002 May 21; 105(20):2416-22. PubMed ID: 12021230
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y.
    Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice.
    Mor A, Kloog Y, Keren G, George J.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):301-5. PubMed ID: 19527709
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.
    Khwaja A, Sharpe CC, Noor M, Kloog Y, Hendry BM.
    Kidney Int; 2005 Aug 15; 68(2):474-86. PubMed ID: 16014024
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis.
    Karussis D, Abramsky O, Grigoriadis N, Chapman J, Mizrachi-Koll R, Niv H, Kloog Y.
    J Neuroimmunol; 2001 Nov 01; 120(1-2):1-9. PubMed ID: 11694313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.